Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Assets Average: 2011-2025

Historic Assets Average for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $702.7 million.

  • Myriad Genetics' Assets Average fell 35.13% to $702.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $702.7 million, marking a year-over-year decrease of 35.13%. This contributed to the annual value of $1.1 billion for FY2024, which is 7.30% down from last year.
  • As of Q3 2025, Myriad Genetics' Assets Average stood at $702.7 million, which was down 16.51% from $841.7 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Assets Average registered a high of $1.4 billion during Q1 2021, and its lowest value of $702.7 million during Q3 2025.
  • In the last 3 years, Myriad Genetics' Assets Average had a median value of $1.1 billion in 2024 and averaged $1.1 billion.
  • Data for Myriad Genetics' Assets Average shows a maximum YoY plummeted of 35.13% (in 2025) over the last 5 years.
  • Myriad Genetics' Assets Average (Quarterly) stood at $1.3 billion in 2021, then dropped by 9.26% to $1.2 billion in 2022, then decreased by 4.77% to $1.1 billion in 2023, then declined by 8.13% to $1.1 billion in 2024, then plummeted by 35.13% to $702.7 million in 2025.
  • Its Assets Average was $702.7 million in Q3 2025, compared to $841.7 million in Q2 2025 and $1.0 billion in Q1 2025.